Company Filing History:
Years Active: 2017
Title: Anna Pietersma: Innovator in Heart Condition Detection
Introduction
Anna Pietersma is a notable inventor based in Doesburg, Netherlands. She has made significant contributions to the field of medical technology, particularly in the detection of heart-related conditions. Her innovative work has the potential to improve patient outcomes and enhance the quality of care in cardiology.
Latest Patents
Anna holds a patent for a "System and method for improved ischemia and acute myocardial infarction detection." This invention provides a system and method for detecting heart-related conditions by obtaining real-time information when a condition is initially identified as potentially occurring. The system detects a physical exercise and recovery episode from physiological signals sensed in a patient. Once detected, a HR-ST segment deviation hysteresis analysis is performed in an implantable medical device (IMD) to identify the probability of a certain condition occurring. When a desired level of probability is reached, data can be transmitted remotely for clinical review and confirmation. Additionally, the patient may be prompted to answer questions related to their symptoms through an input device to further confirm the probability of the condition.
Career Highlights
Anna Pietersma is currently employed at Medtronic, Inc., a leading company in medical technology. Her work at Medtronic focuses on developing innovative solutions that address critical health issues. With her expertise, she has contributed to advancements in medical devices that enhance patient care.
Collaborations
Throughout her career, Anna has collaborated with several professionals in her field, including Willem Boute and David R Hampton. These collaborations have allowed her to share knowledge and drive innovation in heart condition detection.
Conclusion
Anna Pietersma is a pioneering inventor whose work in heart condition detection is making a significant impact in the medical field. Her dedication to innovation and collaboration continues to drive advancements that can improve patient care and outcomes.